Home > Boards > US OTC > Medical - Drugs >

RBC Life Sciences, Inc. (RBCL)

Add RBCL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 12/26/2015 1:12:29 PM - Followers: 8 - Board type: Free - Posts Today: 0

RBC Life Sciences, Inc., together with its subsidiaries, engages in the marketing and distribution of nutritional supplements and personal care products in the United States, Canada, South Korea, and Japan. It operates in two segments, Nutritional Products and Medical Products. The Nutritional Products segment offers a line of approximately 75 nutritional supplements and personal care products, including herbs, vitamins, and minerals, as well as natural skin, hair, and body care products under the RBC Life Sciences brand. It markets these products in four categories: wellness products, weight loss products, fitness products, and skin care products. This segment markets its products through a network of independent distributors, as well as through licensing arrangements with third parties. The Medical Products segment markets a line of approximately 28 wound care and oncology products under the MPM Medical brand throughout the United States. The wound care products are for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. These products include wound and skin cleansers, wound dressings, a moisture barrier cream, and hydrogel wound dressing with Lidocaine. The oncology products are designed to reduce destruction to skin and tissue caused by radiation, and to reduce pain and itching caused by radiation reactions in the skin and the internal mucosa. This segment distributes these products to hospitals, nursing homes, clinics, and pharmacies through medical/surgical supply dealers and pharmaceutical distributors.

Web Sites  

Sample Products

Investment Thesis
1.  Rapidly Growing Earnings - RBCL had record EPS of $0.037 in Q3, the most recent quarter.  Given their backlog, 2008 likely will produce record annual earnings.  2007 earnings were a huge improvement over 2006 ($0.08 in 2007 vs. $0.02 in 2006).  They have a very strong trend of improvement in earnings over a long period of time and I expect that trend to continue.

2.  Huge Backlog - Backlog is $8.7M for their CCI account in the most recent quarter which is the second highest level in history.  Also, the backlog only represents a portion of their sales going forward. They have GM of 47.5% so additional sales drop rapidly to the bottom line.

3.  Rapidly Growing Medical Sales - Medical sales jumped 42% year-over-year and looks like it will continue.  At the end of March they announced an expansion of their medical segment into Latin America.  They also announce in February that they would begin selling their products in Kroger.

4.  Expanding Nutritional Sales -  Nutritional sales increased 23.5% in the most recent quarter due to international expansion.  The company has embarked on some new initiatives to expand their US and Canadian nutritional sales.

5.  Strong Balance Sheet - RBCL has a book value of $0.44 which includes $0.23 in cash.  That puts them in a strong position financially to continue growing.

6.  Recession Resistant Business - Their business is recession resistant which is a strong plus in this economic environment.

Historical Financial Information  

Quarter Revenue Diluted EPS
Q3'09 $6.49M -$0.007
Q2'09 $6.76M $0.012
Q1'09 $6.02M -$0.008
Q4'08 $7.25M  * $0.006
Q3'08  $9.93M  $0.037
Q2'08  $6.89M + $0.012
Q1'08 $6.35M $0.016
Q4'07  $6.63M x $0.008
Q3'07 $7.86M $0.029
Q2'07 $7.15M  $0.023
Q1'07 $5.39M $0.015
Q4'06 $5.28M $0.005
Q3'06  $5.40M $0.004
Q2'06  $6.20M $0.013
Q1'06  $4.81M  -$0.002
Q4'05 $4.95M  $0.003
Q3'05 $4.91M  $0.007
Q2'05  $5.36M  $0.018
Q1'05 $4.14M -$0.000
Q4'04 $5.24M $0.014
Q3'04 $4.07M $0.001
Q2'04 $4.72M $0.007
Q1'04 $4.24M $0.004

* Q4'08 results had unusually high tax at 55.2% vs. 39.6% for the entire year.  If the average tax rate had applied they would have had EPS of $0.008.

+ Q2'08 EPS was impacted by some one-time items. They incurred expenses for an event to train/motivate their sales associates and also had expenses for renovations on their headquarters' building. They
didn't quantify the costs for these one time items but certainly EPS would have been higher without them. I suspect the EPS impact was on the order of $0.008/share. Also they had some shipping delays
that impacted Q2. Without these one-time items the Q2 report would have been much better.

x Without a one-time write-off they would have made $0.023/share. See the following post for details:

Earnings Reports
Q4'08 -
Q3'08 -
Q2'08 -
Q1'08 -
Q4'07 -
Q3'07 -

Backlog Information




Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#180   Just looking NathanH 12/26/15 01:12:28 PM
#179   now why would they need to do a BORN AGAIN 08/09/13 09:46:33 PM
#178   New Symbol: RBCLD. 1-500 (one for five hundred) cantgetmyname 08/09/13 02:40:48 PM
#177   Form 10-K RBC LIFE SCIENCES, INC. For: Dec InvestorStemCell 03/28/13 11:31:17 AM
#176   News..Patent Granted US Patent Granted to RBC Life TyTrades 01/30/13 08:50:30 PM
#175   True that, if one of those pretty girls Penny Roger$ 10/10/11 10:28:11 AM
#174   nice PR here jut needs volume. mrbizzard 10/10/11 09:49:22 AM
#173   RBC Life Sciences Reports Second Quarter 2011 Results Penny Roger$ 08/11/11 09:59:44 AM
#172   Market cap of $8.6M, revenues on pace for Helter Skelter 08/03/10 06:04:18 PM
#171   RBC Life Sciences Reports 16% Second Quarter Sales Growth Helter Skelter 08/03/10 05:25:39 PM
#170   RBC Life Sciences Announces Third Quarter 2009 Results MikeDDKing 11/20/09 02:28:57 PM
#169   Thanks eom SAMNOTSAMUEL 11/10/09 09:01:58 AM
#168   IMO it is a tough call. From MikeDDKing 11/09/09 09:28:38 PM
#167   Unfortunately I still have a tiny position in SAMNOTSAMUEL 11/09/09 04:46:57 PM
#166   RBCL reported a Q3 loss of $0.007/share on MikeDDKing 11/09/09 02:09:49 PM
#165   Yep. It was pretty fluffy. MikeDDKing 11/09/09 09:26:18 AM
#164   That PR belongs in the Fluff Hall of Fame... Knowledge is King 11/09/09 09:22:02 AM
#163   RBC Life Sciences Ranked as One of the MikeDDKing 11/09/09 09:11:06 AM
#162   RBC Life Sciences Unveils the ClearPay System - MikeDDKing 09/08/09 09:09:23 AM
#161   RBC Life Sciences Launches New Initiatives Aimed at MikeDDKing 09/03/09 08:58:32 AM
#160   Study: RBC Life Sciences' Patent-Pending Nutritional Supplement, NeuroBright, MikeDDKing 08/20/09 09:08:34 AM
#159   They reported EPS of $0.012 this quarter which MikeDDKing 08/05/09 09:14:26 AM
#158   RBC Life Sciences Announces Second Quarter 2009 Results MikeDDKing 08/05/09 09:12:50 AM
#157   Horse Study: RBC Life Sciences' Antioxidant, Microhydrin, Reduced MikeDDKing 06/22/09 09:07:20 AM
#156   All Seven Members of RBC Life Sciences' Board MikeDDKing 06/16/09 09:36:46 AM
#155   Thanks Mike. Stockplucks 06/01/09 09:35:46 AM
#154   RBCL has had long term growth and has MikeDDKing 06/01/09 09:13:12 AM
#153   MikeDDKing - If you get a chance, could Stockplucks 05/31/09 11:49:09 AM
#152   On a positive note, they had decent revenue John Bates 05/11/09 10:57:43 AM
#151   RBC Life Sciences' North American Nutritional Supplements and di4 05/08/09 06:34:56 PM
#150   Well that is true. I've thought this rally SSKILLZ1 05/08/09 04:57:04 PM
#149   Of course you ran out of patience... Knowledge is King 05/08/09 04:40:17 PM
#148   Can't say I blame you, I ran out SSKILLZ1 05/08/09 04:15:46 PM
#147   RBCL reports Q1 loss ($.01) vs EPS $.02 Knowledge is King 05/08/09 04:12:37 PM
#146   Leading Nutritional Supplements Firm RBC Life Sciences Chooses MikeDDKing 05/07/09 08:34:50 AM
#145   There isn't any news. MikeDDKing 04/30/09 12:11:53 PM
#144   Any news here? What's driving the drop? TrueFlaco 04/30/09 12:05:36 PM
#143   Came across this one while screen trolling the pappi 04/05/09 03:13:52 PM
#142   Patients Say MPM Medical's Regenecare Gel Significantly Reduced MikeDDKing 03/30/09 09:18:46 AM
#141   Robert Kaiser had more insider purchases as follows: MikeDDKing 03/25/09 10:01:24 AM
#140   Bob Kaiser, Director, bought 7500 @ $.34 Knowledge is King 03/04/09 02:05:31 PM
#139   I verified that CCI revenue is denominated in MikeDDKing 02/26/09 08:29:57 AM
#138   RBCL medical revenue continues to increase. Based upon MikeDDKing 02/25/09 03:36:11 PM
#137   Revenue from the former soviet union was probably MikeDDKing 02/25/09 03:31:44 PM
#136   The 10-K stated the following: "We had MikeDDKing 02/25/09 12:52:50 PM
#135   Mike, these earnings may be built into the nelson1234 02/25/09 10:56:57 AM
#134   For the quarter, revenue was about where I MikeDDKing 02/25/09 10:52:30 AM
#133   Mike, Seems to me that downside is probably limited, SAMNOTSAMUEL 02/25/09 10:22:49 AM
#132   Q4 revenue was $7.25M or a 9% increase MikeDDKing 02/25/09 08:58:54 AM
#131   RBC Life Sciences' 2008 Net Sales Increase 13 MikeDDKing 02/25/09 08:47:40 AM